Secreted GRP78 interacts directly with epidermal growth factor receptor (EGFR), activating the EGFR/SRC/STAT3 signaling pathway, which promotes tumor cell proliferation and counteracts sorafenib-induced apoptosis [96]. Here, HSPA5 is linked to neoplasm.